End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.1 MXN | 0.00% | -2.23% | +20.76% |
Sales 2023 | 16.47B 988M | Sales 2024 * | 17.82B 1.07B | Capitalization | 15.89B 954M |
---|---|---|---|---|---|
Net income 2023 | 1.03B 61.85M | Net income 2024 * | 1.98B 119M | EV / Sales 2023 | 1.07 x |
Net Debt 2023 | 4.52B 271M | Net Debt 2024 * | 3.04B 182M | EV / Sales 2024 * | 1.06 x |
P/E ratio 2023 |
13.1
x | P/E ratio 2024 * |
7.77
x | Employees | 1,783 |
Yield 2023 |
1.38% | Yield 2024 * |
-
| Free-Float | 69.81% |
Latest transcript on Genomma Lab Internacional, S.A.B. de C.V.
1 day | +0.83% | ||
1 week | -1.50% | ||
Current month | +2.33% | ||
1 month | +17.93% | ||
3 months | +29.15% | ||
6 months | +22.84% | ||
Current year | +20.76% |
Managers | Title | Age | Since |
---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | - |
Founder | - | 96-10-29 | |
Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Burkhard Wittek
BRD | Director/Board Member | 70 | 18-04-17 |
Director/Board Member | - | - | |
Founder | - | 96-10-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 15 M€ | -1.62% | - | |
0.04% | 32 M€ | +8.75% | - | |
0.01% | 4 M€ | -4.41% | - | |
0.01% | 112 M€ | +5.51% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 17.1 | 0.00% | 3,143,736 |
24-05-15 | 17.1 | +0.83% | 5,776,938 |
24-05-14 | 16.96 | -1.85% | 2,451,974 |
24-05-13 | 17.28 | -0.29% | 1,752,150 |
24-05-10 | 17.33 | -0.91% | 2,873,264 |
End-of-day quote Mexican S.E., May 14, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.76% | 944M | |
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.27% | 171B |
- Stock Market
- Equities
- LAB B Stock